End of Pfizer trial paves way for a Covid shot this year ...Qatar

Gulf Times - News
End of Pfizer trial paves way for a Covid shot this year
* Drugmaker to apply for emergency US approval within days * Pfizer says efficacy consistent across age, ethnic groups * Efficacy in vulnerable over-65s was over 94%, company says * Health workers would be prioritized for vaccinations * Mass rollout to take months, complicated by cold storage  Final results from Pfizer Inc's Covid-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency US authorization within days, it said on Wednesday. The efficacy rate of the vaccine developed by Pfizer and its German partner BioNTech is the highest of any candidate in late-stage clinical trials so far, and

Read More Details
Finally We wish PressBee provided you with enough information of ( End of Pfizer trial paves way for a Covid shot this year )

Apple Storegoogle play

Also on site :



Latest News